CORRECTING and REPLACING Agilent to Showcase Next-Generation Digital Pathology Solutions at USCAP 2025
Agilent Technologies (NYSE: A) has announced its participation in the USCAP Conference from March 22-27, 2025, in Boston, where it will showcase advanced digital pathology solutions. The company has developed an end-to-end digital pathology workflow in collaboration with Hamamatsu, PathAI, Proscia, and Visiopharm.
The integrated solution combines AI-driven precision pathology software with automated staining solutions, covering processes from tissue sample scanning to image analysis and data management. Key products to be showcased include the Magnis NGS Prep System and NovoCyte Opteon Spectral Flow Cytometer.
Two significant symposiums are scheduled for March 24: a Digital Pathology Symposium (12:00-1:00 PM ET) featuring experts from various institutions, and a Medical Affairs Symposium on PD-L1 Heterogeneity (5:30-7:00 PM ET). Visitors can explore these innovations at Agilent booth #512.
Agilent Technologies (NYSE: A) ha annunciato la sua partecipazione alla Conferenza USCAP dal 22 al 27 marzo 2025 a Boston, dove presenterà soluzioni avanzate di patologia digitale. L'azienda ha sviluppato un flusso di lavoro di patologia digitale end-to-end in collaborazione con Hamamatsu, PathAI, Proscia e Visiopharm.
La soluzione integrata combina software di patologia di precisione basato su AI con soluzioni di colorazione automatizzate, coprendo i processi dalla scansione dei campioni di tessuto all'analisi delle immagini e alla gestione dei dati. I principali prodotti che saranno presentati includono il sistema Magnis NGS Prep e il citometro a flusso spettrale NovoCyte Opteon.
Due importanti simposi sono programmati per il 24 marzo: un Simposio di Patologia Digitale (12:00-1:00 PM ET) con esperti di varie istituzioni e un Simposio di Affari Medici sulla Eterogeneità del PD-L1 (5:30-7:00 PM ET). I visitatori possono esplorare queste innovazioni presso lo stand #512 di Agilent.
Agilent Technologies (NYSE: A) ha anunciado su participación en la Conferencia USCAP del 22 al 27 de marzo de 2025 en Boston, donde mostrará soluciones avanzadas de patología digital. La compañía ha desarrollado un flujo de trabajo de patología digital de extremo a extremo en colaboración con Hamamatsu, PathAI, Proscia y Visiopharm.
La solución integrada combina software de patología de precisión impulsado por IA con soluciones de tinción automatizadas, abarcando procesos desde la escaneado de muestras de tejido hasta el análisis de imágenes y la gestión de datos. Los productos clave que se mostrarán incluyen el sistema Magnis NGS Prep y el citómetro de flujo espectral NovoCyte Opteon.
Dos simposios significativos están programados para el 24 de marzo: un Simposio de Patología Digital (12:00-1:00 PM ET) con expertos de diversas instituciones, y un Simposio de Asuntos Médicos sobre la Heterogeneidad del PD-L1 (5:30-7:00 PM ET). Los visitantes pueden explorar estas innovaciones en el stand #512 de Agilent.
Agilent Technologies (NYSE: A)는 2025년 3월 22일부터 27일까지 보스턴에서 열리는 USCAP 컨퍼런스에 참여하여 첨단 디지털 병리 솔루션을 선보일 것이라고 발표했습니다. 이 회사는 Hamamatsu, PathAI, Proscia 및 Visiopharm과 협력하여 엔드 투 엔드 디지털 병리 작업 흐름을 개발했습니다.
통합 솔루션은 AI 기반 정밀 병리 소프트웨어와 자동 염색 솔루션을 결합하여 조직 샘플 스캔부터 이미지 분석 및 데이터 관리에 이르는 프로세스를 포괄합니다. 전시될 주요 제품으로는 Magnis NGS Prep 시스템과 NovoCyte Opteon 스펙트럼 흐름 세포계측기가 있습니다.
3월 24일에는 두 개의 중요한 심포지엄이 예정되어 있습니다: 다양한 기관의 전문가들이 참여하는 디지털 병리 심포지엄 (오후 12:00-1:00 ET)과 PD-L1 이질성에 대한 의료 affairs 심포지엄 (오후 5:30-7:00 ET). 방문객들은 Agilent 부스 #512에서 이러한 혁신을 탐색할 수 있습니다.
Agilent Technologies (NYSE: A) a annoncé sa participation à la Conférence USCAP du 22 au 27 mars 2025 à Boston, où elle présentera des solutions avancées de pathologie numérique. L'entreprise a développé un flux de travail de pathologie numérique de bout en bout en collaboration avec Hamamatsu, PathAI, Proscia et Visiopharm.
La solution intégrée combine logiciel de pathologie de précision basé sur l'IA avec des solutions de coloration automatisées, couvrant les processus allant du scan des échantillons de tissu à l'analyse d'images et à la gestion des données. Les principaux produits qui seront présentés incluent le système Magnis NGS Prep et le cytomètre de flux spectral NovoCyte Opteon.
Deux symposiums importants sont prévus pour le 24 mars : un Symposium de Pathologie Numérique (12:00-1:00 PM ET) avec des experts de diverses institutions, et un Symposium sur les affaires médicales concernant l'hétérogénéité du PD-L1 (5:30-7:00 PM ET). Les visiteurs peuvent explorer ces innovations au stand #512 d'Agilent.
Agilent Technologies (NYSE: A) hat seine Teilnahme an der USCAP-Konferenz vom 22. bis 27. März 2025 in Boston angekündigt, wo es fortschrittliche digitale Pathologielösungen präsentieren wird. Das Unternehmen hat in Zusammenarbeit mit Hamamatsu, PathAI, Proscia und Visiopharm einen End-to-End-Workflow für digitale Pathologie entwickelt.
Die integrierte Lösung kombiniert KI-gesteuerte Präzisionspathologie-Software mit automatisierten Färbelösungen und deckt Prozesse von der Gewebeproben-Scannung bis zur Bildanalyse und Datenverwaltung ab. Zu den wichtigsten Produkten, die vorgestellt werden, gehören das Magnis NGS Prep System und der NovoCyte Opteon Spektral-Flusszytometer.
Zwei bedeutende Symposien sind für den 24. März geplant: ein Digital Pathology Symposium (12:00-1:00 PM ET) mit Experten aus verschiedenen Institutionen und ein Symposium über medizinische Angelegenheiten zur PD-L1-Heterogenität (5:30-7:00 PM ET). Besucher können diese Innovationen am Agilent Stand #512 erkunden.
- None.
- None.
The updated release reads:
AGILENT TO SHOWCASE NEXT-GENERATION DIGITAL PATHOLOGY SOLUTIONS AT USCAP 2025
Agilent Technologies Inc. (NYSE: A) is excited to announce its participation at the upcoming
In pathology, Agilent offers comprehensive tissue diagnostic solutions for analyzing tissue samples, often for diagnosing diseases such as cancer. In collaboration with Hamamatsu, PathAI, Proscia, and Visiopharm, Agilent has developed an innovative end-to-end digital pathology workflow. This solution integrates AI-driven precision pathology software with automated staining solutions, significantly improving diagnostic quality and efficiency. Agilent's workflow covers everything from scanning tissue samples to analyzing images and managing data, incorporating advanced technologies like AI to enhance accuracy and efficiency.
"Agilent's innovative pathology solutions are transforming health care by ensuring precise, timely, and reliable diagnoses. Our comprehensive digital pathology workflows and advanced staining technologies enable laboratories to deliver accurate and comprehensive results, facilitating faster and more effective treatments,” said Nina Green, vice president and general manager of the Clinical Diagnostics Division at Agilent. “By reducing the time from biopsy to diagnosis and enhancing diagnostic consistency, we help support better therapeutic decisions."
USCAP attendees are invited to live demonstrations of Agilent’s digital pathology solutions, including scanning, image management, and AI-driven image analysis. Covering primary, special, IHC, and ISH staining, Agilent’s automated, integrated, and advanced tissue staining solutions deliver consistent, high-quality results, helping laboratories enhance productivity and reduce the time from biopsy to diagnosis. Agilent will also showcase key products that play crucial roles in pathology labs including the Magnis NGS Prep System and the NovoCyte Opteon Spectral Flow Cytometer.
Additionally, a Digital Pathology Symposium, “Advancing Diagnostics: Cutting-Edge Innovations and Insights in Digital Pathology,” will be held Monday, March 24, from 12:00–1:00 PM ET, featuring presenters including Dr. Douglas Clark and Jake Eden from Agilent, Dr. Orly Ardon from Memorial Sloan Kettering Cancer Center, Dr. Dominique Coco from Cellnetix Olympia, Dr. Anil Parwani from The Ohio State University, and Dr. Brian Robinson from Weill Cornell Medicine. A Medical Affairs Symposium, “PD-L1 Heterogeneity Across the Patient Journey,” will also be held Monday, March 24, from 5:30–7:00 PM ET, and presented by Dr. Matteo Fassan from the University of Padua in
For more information about these events and Agilent's pathology solutions, visit the USCAP Agilent booth #512.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of
View source version on businesswire.com: https://www.businesswire.com/news/home/20250320022736/en/
Media Contact
Naomi Goumillout
Agilent Technologies
+1.978.314.1862
naomi.goumillout@agilent.com
Source: Agilent Technologies Inc.
FAQ
What new digital pathology solutions will Agilent (NYSE: A) showcase at USCAP 2025?
When and where are Agilent's symposiums scheduled during USCAP 2025?
Who are Agilent's key collaboration partners for their digital pathology workflow?
What are the main benefits of Agilent's new digital pathology workflow?
Where can attendees find Agilent's digital pathology demonstrations at USCAP 2025?
